Cargando…

microRNA-199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin

microRNAs (miRNAs/miRs) may have a crucial function in tumor metastasis through the regulation of a plethora of signaling pathways. Increasing evidence has shown that miR-199a is important in regulating the tumor metastasis of ovarian cancer, although the precise biological function of miR-199a is u...

Descripción completa

Detalles Bibliográficos
Autores principales:	WANG, ZHONGXIAN, TING, ZHOU, LI, YA, CHEN, GANG, LU, YUNPING, HAO, XING
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789061/ https://www.ncbi.nlm.nih.gov/pubmed/24137412 http://dx.doi.org/10.3892/ol.2013.1448

Ejemplares similares

Overview of microRNA-199a Regulation in Cancer
por: Wang, Qiwen, et al.
Publicado: (2019)

A sense-able microRNA
por: Pasquinelli, Amy E.
Publicado: (2016)

Circular RNA SET domain protein 3 promotes nasopharyngeal carcinoma proliferation, cisplatin resistance, and protein kinase B / mammalian target of rapamycin pathway activation by modulating microRNA-147a expression
por: Deng, Gang, et al.
Publicado: (2022)

Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer
por: Ali, Fahmy T., et al.
Publicado: (2022)

MicroRNA-199a-3p inhibits ovarian cancer cell viability by targeting the oncogene YAP1
por: He, Yanfang, et al.
Publicado: (2021)

MicroRNA-199a-3p inhibits ovarian cancer cell viability by targeting the oncogene YAP1
por: He, Yanfang, et al.
Publicado: (2022)

MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells
por: Moghbeli, Meysam
Publicado: (2021)

miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8
por: Cui, Yajie, et al.
Publicado: (2018)

microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity
por: Martin, Elizabeth C, et al.
Publicado: (2014)

miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α
por: Feng, Xue, et al.
Publicado: (2017)

The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma
por: Kinose, Yasuto, et al.
Publicado: (2015)

Flexible and Versatile as a Chameleon—Sophisticated Functions of microRNA-199a
por: Gu, Shen, et al.
Publicado: (2012)

MicroRNA-199a-3p and microRNA-34a regulate apoptosis in human osteosarcoma cells
por: Tian, Ye, et al.
Publicado: (2014)

Molecular Mechanisms of Regulation and Action of microRNA-199a in Testicular Germ Cell Tumor and Glioblastomas
por: Gu, Shen, et al.
Publicado: (2013)

Inhibition of mammalian target of rapamycin by rapamycin increases the radiosensitivity of esophageal carcinoma Eca109 cells
por: ZHANG, DEJUN, et al.
Publicado: (2014)

Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma
por: Zhang, Kun, et al.
Publicado: (2020)

Melatonin regulates the ovarian function and enhances follicle growth in aging laying hens via activating the mammalian target of rapamycin pathway
por: Hao, Er-ying, et al.
Publicado: (2020)

microRNA-106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells
por: LI, HAO, et al.
Publicado: (2014)

Chemical Inhibitors and microRNAs (miRNA) Targeting the Mammalian Target of Rapamycin (mTOR) Pathway: Potential for Novel Anticancer Therapeutics
por: AlQurashi, Naif, et al.
Publicado: (2013)

MicroRNA-199a-5p Affects Porcine Preadipocyte Proliferation and Differentiation
por: Shi, Xin-E, et al.
Publicado: (2014)

MicroRNA 199a-5p induces apoptosis by targeting JunB
por: Yan, Mengjie, et al.
Publicado: (2018)

MicroRNA-199: A Potential Therapeutic Tool for Hepatocellular Carcinoma in an Experimental Model
por: Atta, Shimaa, et al.
Publicado: (2021)

MicroRNA-mRNA functional pairs for cisplatin resistance in ovarian cancer cells
por: Liu, Mei, et al.
Publicado: (2014)

MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1
por: Tian, Songyu, et al.
Publicado: (2016)

MicroRNAs and the cellular response to rapamycin: Potential role in diagnosis and therapy
por: Totary-Jain, Hana, et al.
Publicado: (2013)

Retraction: Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma
Publicado: (2022)

Prognostic significance and function of mammalian target of rapamycin in tongue squamous cell carcinoma
por: Li, Shau-Hsuan, et al.
Publicado: (2017)

Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
por: Groenewoud, Marlous J., et al.
Publicado: (2013)

MicroRNA199a-Based Post-transcriptional Detargeting of Gene Vectors for Hepatocellular Carcinoma
por: Dhungel, Bijay, et al.
Publicado: (2018)

Export of microRNAs and microRNA-protective protein by mammalian cells
por: Wang, Kai, et al.
Publicado: (2010)

Annotation of mammalian primary microRNAs
por: Saini, Harpreet K, et al.
Publicado: (2008)

The MicroRNA Biology of the Mammalian Nucleus
por: Roberts, Thomas C
Publicado: (2014)

Metformin potentiates rapamycin and cisplatin in gastric cancer in mice
por: Yu, Yu, et al.
Publicado: (2015)

Expression of Concern: Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma
Publicado: (2022)

MicroRNA-199a and -214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor
por: Kuninty, Praneeth R., et al.
Publicado: (2016)

microRNA-199a-3p inhibits hepatic apoptosis and hepatocarcinogenesis by targeting PDCD4
por: Li, Zhenyang, et al.
Publicado: (2020)

PPAR Gamma-Regulated MicroRNA 199a-5p Underlies Bone Marrow Adiposity in Aplastic Anemia
por: Zhang, Xianning, et al.
Publicado: (2019)

Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
por: Kim, Won Seop
Publicado: (2011)

SIRT1 Negatively Regulates the Mammalian Target of Rapamycin
por: Ghosh, Hiyaa Singhee, et al.
Publicado: (2010)

Mammalian target of rapamycin signaling in diabetic cardiovascular disease
por: Chong, Zhao Zhong, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5kt9gna15hsd1ujv1ckh3ntm3r